Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Yu Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5394-1686; OpenAlex author ID A5034272953, A5122337471. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 2 papers

Papers 3

  1. Uncovering the potential of pathomics: prognostic prediction and mechanistic investigation of pancreatic cancer. Last author DOI 10.1002/path.70011↗
  2. OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression. Last author DOI 10.1016/j.drup.2026.101469↗
  3. ITGB6 promotes pancreatic fibrosis and aggravates the malignant process of pancreatic cancer via JAK2/STAT3 signaling pathway. Co-author DOI 10.1007/s00210-024-03003-z↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Long Liu · 1 shared paper, 2026 · strength 0.32
  2. Long Liu · 1 shared paper, 2026 · strength 0.26
  3. Shihang Xi · 1 shared paper, 2024 · strength 0.23
  4. Daohai Qian · 1 shared paper, 2024 · strength 0.23
  5. Xiaoming Wang · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.